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Abstract
Background: The extracts of Plumbago zeylanica have been used in China and other Asian countries as folk
medicine for the treatment of cancer, rheumatoid arthritis and dysmenorrhoea. Effect of Plumbagin (5-hydroxy-2-
methyl-1,4-naphthoquinone) purified from Plumbago zeylanica on Con A induced T cell proliferation was studied in
spleen cells from collagen induced arthritic DBA/1 mice.
Methods: The DBA/1 mice (five per each group) were immunized with 0.1 mL of collagen (emulsified in CFA) by
intradermal injection at the base of the tail. On day 20, mice were given a booster dose of collagen (emulsified in
IFA) through the same route. Plumbagin was given at different concentrations (3.3, 6.6, 13.3 mg/kg body weight)
intraperitoneally. Control mice received olive oil alone. The Con A induced T cell proliferative responses of arthritic
and Plumbagin treated mice were studied by cell culture experiments using tritiated Thymidine. In addition the
cytokine levels were estimated from the in vitro spleen culture supernatants of arthritic mice primed with different
concentrations of Plumbagin by ELISA.
Results: Plumbagin enhanced the decreased Con A induced T cell proliferation and Interleukin-2 production in
arthritic mice. Moreover elevated levels of IFN- g were found to be decreased in Plumbagin treated spleen cell
culture supernatants. Subclasses of IgG were found to be decreased by Plumbagin treatment, IgG2a reduction
seems to be more prominent.
Conclusion: The results obtained in the current study indicate that Plumbagin is very effective in the mechanism
based treatment of Rheumatoid arthritis.
Background
Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), a
quinone isolated from the roots of Plumbago zeylanica
was recently reported to suppress the activation of NF-
kappa B in tumor cells [1]. T cells and their cytokine
products are the causative factors of autoimmune dis-
eases, including Rheumatoid arthritis. For the induction
of arthritis either self reactive T cells must be present in
the immunological repertoire or self antigen must be
present in conjunction with major histocompatibility
complex class II determinants on competent antigen
presenting cells. The CD4+ T cell population contains
subsets Th1 and Th2 cells, which have been
characterized in murine system and have been shown to
differ in the secretion of cytokines. Thus Th1 cells can
be shown to be the source of IL-2 and Interferon- g and
promote cell mediated immune response. The impor-
tance of IFN- g as a local mediator of inflammation in
RA has also been confirmed in collagen induced arthri-
tis. Thus local injection of IFN- g into the footpads of
collagen type II immunized mice accelerates the onset
of arthritis and increases the severity of disease [2]. Up
regulation of adhesion molecule expression on vascular
endothelium by IFN- g may also promote the homing of
lymphocytes and neutrophils to the affected tissues. The
quantitative analysis suggests that there are few T cell
derived cytokines such as Interleukin-2 (IL-2), Tumour
necrosis factor-a (TNF-a), IL-1 and IFN-g in inflamed
synovial tissue.
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ate to high concentrations in Rheumatoid arthritis (RA).
TNF-a and IL-1 are both present in large quantities in
synovial fluid and synovial tissue. The immunohisto-
chemical and mRNA in situ hybridization analysis has
shown the presence of these cytokines in cells of syno-
vial lining and sublining, including type A synoviocytes
and other macrophage like populations [3,4]. To provide
a means for homeostasis and downregulation of inflam-
matory responses, a subclass of cytokines and cytokine
receptors are thought to exert anti-inflammatory action
in the synovium. There are two TNF receptors, both of
which occur naturally in synovial fluid in soluble form,
inhibiting TNF-a activity by competing with cell surface
receptors for binding [5]. Similarly the two IL-1 recep-
tors (IL-1R1and IL-1R2) also occur in soluble form in
synovial fluid. These receptors are capable of binding
IL-1, thus forming competition for cell surface receptors
[6]. Additionally, a naturally occurring competitive inhi-
bitor for IL-1 at the IL-1 receptor (IL-1 receptor antago-
nist IL-1RA) is also present in RA synovial fluid [7].
This member of IL-1 family binds itself to IL-1R1 with-
out transducing a signal, thus blocking the receptor
binding ability of IL-1. Results of work in animals have
suggested a central role of TNF-a and IL-1 in the pro-
cess of synovitis and joint destruction. Addition of exo-
genous TNF-a or IL-1 into experimental models of
arthritis induces synovitis. Furthermore, mice transgenic
for TNF-a, and mice with disregulated TNF-a produc-
tion develop arthritis [8,9]. The treatment of murine
models of arthritis with antibodies against TNF-a and
IL-1 or with soluble TNF-a, receptor ameliorates or
abrogates the disease [10,11].
Methods
Plumbago zeylanica was collected in Paderu tribal area,
Visakhapatnam, India and was authenticated by taxono-
mist Prof. B. Venkayya of the Botany department,
Andhra University, India. A voucher specimen (4232)
was deposited in herbarium of the Department of Bot-
any, Andhra University.
Preparation of ethanol extract of Plant
The alcoholic solubles (AS) were separated by vacuum
filtration using a rotavapor. The resultant residue was
freeze-dried to remove traces of alcohol. AS fraction
was further separated to different fractions by using
silica gel column chromatography using different
organic solvents. Briefly activated silica gel was packed
in a glass column (75 × 1 cm) up to 60 cm. The column
was pre incubated with benzene and the above AS frac-
tion (dissolved in 2 ml ethanol) was loaded on the top
of the column and eluted with different organic solvents
of increasing polarity
. The elution was carried out
stepwise, with benzene, benzene: chloroform (1:1),
chloroform, chloroform: ethylacetate (1:1), ethyl acetate:
dichloromethane (1:1), dichloromethane, dichloro-
methane: ethanol (1:1) and ethanol. The vacuum evapo-
rated fractions are further separated into six fractions
and were designated as PZE-1, PZE-2, PZE-3, PZE-4,
PZE-5 and PZE-6 (Plumbagin) with 5-30% ethyl acetate
in benzene. These fractions were freeze dried and dis-
solved in olive oil for the current investigation.
Animals
Male DBA/1 (H-2q) mice (8 weeks old) weighing
around 30 gms were procured from the experimental
animal facility of the National Institute of Immunology,
New Delhi, India. The experimental protocol was
approved by the Institutional ethics committee, Andhra
University, Visakhapatnam, Andhra Pradesh, India.
Chemicals and Materials
Bovine Type II collagen, Freund’s Complete Adjuvant
(FCA), Incomplete Freund’sA d j u v a n t( I F A ) ,G o a ta n t i -
m o u s eI g G ,B o v i n eS e r u mA l b u m i n( B S A ) ,O - p h e n y l e -
nediamine (OPD), Hydrogen peroxide, RPMI-1640,
Hank’s balanced salt solution
(HBSS), Fetal Calf Serum (FCS), Ammonium Chloride
and Streptavidin purchased from Sigma Chemical Com-
pany (St. Louis, MO, USA). Tritiated thymidine was
supplied by Bhabha Atomic Research Centre (BARC),
Mumbai, India. 96-well microtiter flat-bottom ELISA
culture plates (Nunc, Denmark) were procured.
Preparation of emulsified formulation of Type II collagen
Type II collagen (4 mg) was solubilized in 1 ml of 0.05
M acetic acid. Equal volumes of collagen solution were
emulsified with FCA and IFA [12].
Thin layer chromatography
Thin layer chromatography was performed to check the
purity of the sample. Silica gel was manually coated
onto the glass plate along with an adsorbent. Benzene:
Chloroform (4:5) was used as a solvent. 5% alcoholic
H2SO4 and Iodine were used to visualize the spots.
1H NMR Spectroscopic analysis of Plumbagin
Plumbagin fraction was analyzed on Gemini-200 MHz
1H NMR Spectrometer at Indian Institute of Chemical
Technology, Hyderabad, India. The
1H NMR spectra of
Plumbagin were recorded in CDCl3 with Trimethyl
silane (TMS) as internal standard at room temperature.
Statistical Analysis
Results were expressed as the average values with stan-
dard deviation (mean ± SD). Statistical significance was
determined by Two-way analysis of variance (ANOVA)
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software. Significance was set at p ≤ 0.05
Immunization
The mice were (5 mice for each group) immunized with
0.1 ml of collagen with FCA (emulsion-A) by intrader-
mal injection at the base of tail. On day 21, after pri-
mary immunization, mice were intradermally given a
booster dose of collagen along with IFA (emulsion-B) at
the same site.
Treatment
Plumbagin was dissolved in olive oil at different concen-
trations (3.33, 6.66, 13.33 mg/kg body weight) and given
intraperitoneally in a volume of 100 μl, weekly thrice for
six weeks, starting from day 0 to day 42. Control mice
received olive oil alone during this period. Indomethacin
(3 mg/kg) was given intraperitoneally.
Determination of antitype II collagen antibodies serum
(ELISA method)
Retro orbital blood samples from arthritic mice were
collected at 3, 5, 7 weeks after primary immunization
and centrifuged at 2000 rpm for 10 min to get the
required serum. Sera samples were diluted with saline.
Microtitre plate (ELISA) was coated with type II col-
lagen kept for overnight, and then
blocked with 50 μl of 2% BSA in PBS for 90 min at
room temperature. The plate was washed 4 times with
PBS (pH 7.5), 0.005% tween 20 (wash buffer) 50 μlo f
dilute sera was added to each well and then incubated
for 60 min at room temperature. The plate was again
washed 4 times with wash buffer. The peroxidase
labelled rabbit anti-mouse IgG 50 μl/well (in 0.6 mol/lit
NaCl, 0.26 mol/lit H3PO4 and 0.08 N NaOH, pH 9.6)
was added to each well as the secondary antibody and
incubated for 1 hour at room temperature. The plate
was washed and 100 μl of 1.5 M citrate phosphate buf-
fer containing OPD and 100 μlo fH 2O2 were added.
The reaction was stopped after 5 min by adding 50 μlo f
2N H2SO4. Colour developed was read at 490 nm using
ELISA reader (Bio-rad model-550).
T cell proliferation assay
For testing the effect of Plumbagin on con A induced T
cell proliferation, On day 12 mice were sacrificed and
their spleens were collected. T cells were isolated
according to the procedure of Francis et al (1990) [13].
Briefly, the spleens were teased to get single cell suspen-
sion by incubating with 1 ml of 0.9% NH4Cl for 1 min
at 37 °C, followed by arresting the activity of NH4Cl by
adding RPMI twice the volume of the incubation mix-
ture. The cells were washed and suspended in RPMI
and incubated in a Petri dish coated with goat anti-
mouse immunoglobulins at 1:1000 dilutions in PBS to
remove the B cell population. The unbound cells were
carefully separated and resuspended in FCS. The viabi-
lity of cells was checked with tryphan blue exclusion
[14]. These purified cells were employed in Ovalbumin
induced T cell proliferation assay. T cell proliferation
and cell cultures were carried out in sterile microtitre
plates with 96 flat bottom wells. All the reagents used
were filter sterilized using 0.22 nunc millipore filters
prior to adding into the wells. For each individual assay,
the cultures were done in triplicate, with each well con-
taining 2 × 10
5 cells in 250 μl RPMI medium.
Cells were stimulated with Ovalbumin in absence or
presence of different doses of PZE. Cultures were incu-
bated for 72 h at 37 °C in a humified 5% CO2 modula-
tor chamber. After 18 h the cultures were incubated
with tritiated thymidine (0.5 μci/well).After incubation
period, cells were harvested on glass fibre filters, using
Nunc cell harvester and the thymidine incorporation
was determined by liquid scintillation counter by adding
5 ml of scintillation fluid and 500 mg of 1,4 -bis{5-phe-
nyl-2-oxazole}- benzene: 2,2’-p -p h e n y l e n e - b i s{ 5 - p h e -
nyl- oxazole} per litre. The results were expressed as
counts per minutes (cpm) and plotted against culture
blanks, concentrations of Con A and Plumbagin.
Assay of Cytokines
The estimation of cytokines was carried out using the
culture supernatants from the in vitro spleen cell cul-
tures for T cell assay. The spleen cells were collected
from mice primed with different concentrations of
Plumbagin. In vitro pulsing was done with Con A at a
concentration of 1 μg. Spleen cell culture supernatants
from unprimed mice treated with media and arthritic
mice treated with media were used as controls. The
supernatant for IL-2 estimation was collected after 24
hours culture while for IFN- g estimation, it was col-
lected after 72 hrs culture. The R&D cytokine assay
(ELISA) kit was used for estimation. Briefly, the plate
was coated with 100 μl of capture antibody (anti-mouse
IFN-g or IL-2) diluted in PBS (1 in 2000) and incubated
overnight at room temperature. The plate was aspirated
and washed thrice with wash buffer (0.5% tween-20 in
PBS) using a multi channel pipette. Complete removal
of liquid in each step was ensured and blotted against a
clean paper after last wash. The wells were blocked with
300 μl of block buffer (1% BSA in PBS with 0.05%
NaNO3) and incubated at room temperature for one
hour. Again the plate was aspirated and washed. 100 μl
of standards (recombinant mouse IFN-g or IL-2) or cul-
ture supernatants primed with different concentrations
of Plumbagin diluted in reagent diluents were added
and plate was incubated for 2 hrs. After that the plate
was aspirated, washed and incubated for 2 hrs with 100
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IFN-g or IL-2, diluted in reagent diluent).
Then 100 μl of diluted streptavidin (conjugated to
horse raddish peroxidase, diluted in 1 in 1000 in reagent
diluent) was added to each well and the plate was incu-
bated for 20 min at room temperature. Exposing the
plate to direct sunlight was avoided. The plate was aspi-
rated, washed and incubated at room temperature for
20 min with substrate solution (1:1 mixture of H2O2)
and trimethyl benzedene) of 100 μl per well. The plate
was read at 450 nm after stopping the reaction with 50
μl/well of stopping solution (2N H2SO4).
Results
We have previously reported that PZE-6, ethyl acetate
fraction of Plumbago zeylanica reduced the clinical
score of the disease in CIA mice [15].Our findings in
Figure 1 have shown that 3.3 mg/kg body weight of
Plumbagin was significantly decreased the anti-collagen
II antibodies determined by ELISA. All the four sub-
classes of type II collagen specific IgG (IgG1, IgG2a,
IgG3 and IgG4) antibody responses in the Plumbagin
treated groups were observed to be decreased through-
out the experiment. Plumbagin (3.3 mg/kg body weight)
significantly suppresses the I g G 2 ar e s p o n s e s( F i g u r e2 ) .
Dose dependant suppression of antibody response to
collagen type II was also observed in Plumbagin treated
groups (3.33, 6.66 and 13.33 mg/kg) with the compari-
son of Indomethacin (3 mg/kg body weight) treated
group as shown in the Figure 3. The results in Figure 4
revealed that the Con A induced T cell proliferative
r e s p o n s eo fa r t h r i t i cm i c ew a sf o u n dt ob ed e c r e a s e d
significantly when compared to the T cell response of
normal mice. However, the Plumbagin treatment of
arthritic mice restored considerably the decrease of T
cell proliferative response. The cytokine levels were esti-
mated from the in vitro spleen T cell culture superna-
tants of arthritic mice primed with different
Figure 1 E f f e c to fP l u m b a g i no nc o l l a g e nt y p eI Ii n d u c e d
arthritis. Arthritis was induced in two groups (5 per each group) of
mice by injecting collagen type II (CII) along with complete Freund’s
adjuvant (CII+CFA). Control group with CFA alone. Booster dose was
given on day 21. One arthritic group was treated with Plumbagin
(PZE-6) another treated with olive oil alone. Retroorbital sera were
collected at 3, 5, 7 week intervals for the estimation of anti-type II
collagen antibody (IgG) by ELISA. Bars represent means±SEM from n
= 5. p-value≤0.05 was significant.
Figure 2 Effect of Plumbagin on elicitation of Ig G subclasses
specific to collagen type II arthritis. Two groups of DBA/1 mice
were immunized with 0.1 ml of bovine type II collagen along with
CFA intradermally at the base of the tail. Booster dose was given on
day 21. Test group was treated with Plumbagin. Control mice were
treated with olive oil alone. Retroorbital sera were collected at 3, 5,
7 week intervals after primary immunization for the estimation of
IgG subclasses by ELISA. p-value≤0.05 was significant.
Figure 3 Dose effect of Plumbagin on collagen Type II induced
arthritis. Five groups of DBA/1 mice were immunized with 0.1 ml
of bovine type II collagen intradermally at the base of the tail.
Booster dose was given 3 weeks after primary immunization. Test
groups were treated with Plumbagin (3.3 mg/kg), (6.6 mg/kg) and
(13.3 mg/kg) and Indomethacin (3 mg/kg) respectively. Control mice
were treated with olive oil alone. Retroorbital sera were collected at
3, 5, 7 week intervals after primary immunization for the estimation
of anti-type-II collagen antibody (IgG) by ELISA. p-value≤0.05 was
significant.
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kg body weight). Pulsing was done with 1μg concentra-
tion of Con A. the supernatants from 24 hr cultures
were used for IL-2 estimation however for IFN- g esti-
mation, it was collected after 72 hrs. The results in Fig-
ure 5 demonstrated that with increase of Plumbagin
concentration the IL-2 levels seems to be elevated to the
normal levels in treated CIA mice. Consequently the
down regulation of IFN- g levels were observed in dose
dependent manner in culture supernatants of T cells
(Figure 6).
Discussion
Trentham et al (1977) [12] induced arthritis in animal
model by injecting type II collagen as an experimental
model that is similar to human rheumatoid arthritis in
several of its clinical and immunological manifestations.
In this collagen induced arthritis (CIA) mouse model.
Plumbagin (3.33 mg/kg body weight) could suppress the
total anti collagen IgG responses significantly as deter-
mined by ELISA. Although all the four subclasses of
IgG were decreased by Plumbagin treatment, IgG2a
reduction seems to be more prominent. The disease sus-
ceptibility is also related to autoantibody isotype, Predo-
minance of IgG2a isotype is associated with arthritis
Figure 4 Effect of Plumbagin on Con A induced T cell
proliferation in collagen Type II induced arthritis. Two groups of
DBA/1 mice immunized with 0.1 ml of bovine type II collagen
intradermally at the base of the tail. Booster dose was given on day
21. Normal group did not receive any injection. Test group was
treated intraperitoneally with Plumbagin. Control group was treated
with vehicle alone. At the end of the experiment mice were
sacrificed, and Spleenic T lymphocytes isolated from arthritic mice,
Plumbagin treated mice and normal mice were incubated with 1μg
and 2μg of Con A and maintained the conditions similar to the
previous culture experiments. Cultures were pulsed with 0.5 μci of
radioactive thymidine per well and the incorporation of radioactivity
was measured in scintillation counter after 18 hours of incubation.
Native T cells without Con A stimulation served as blank. p-
value≤0.05 was significant.
Figure 5 E f f e c to fP l u m b a g i no nI L - 2p r o d u c t i o ni nc o l l a g e n
Type II induced arthritis mice. Four groups of DBA/1 mice were
immunized with 0.1 ml of bovine type II collagen intradermally at
the base of the tail. Booster dose was given 3 weeks after primary
immunization. Normal group did not receive any injection. Test
groups were treated intraperitoeally with Plumbagin (3.3 mg/kg),
(6.6 mg/kg) and (13.3 mg/kg) respectively. Control group was
treated with vehicle alone. At the end of the experiment, mice were
sacrificed and Spleenic T lymphocytes isolated from arthritic mice,
PZE treated mice and normal mice were incubated with 1μg and 2
μg of Con A and maintained the conditions similar to the previous
culture experiments. Cultures supernatants were collected and IL-2
production was estimated by ELISA. p-value≤0.05 was significant.
Figure 6 Effect of Plumbagin on the production of IFN-g in
collagen Type II induced arthritis mice. Four groups of DBA/1
mice were immunized with 0.1 ml of bovine type II collagen
intradermally at the base of the tail. Booster dose was given 3
weeks after primary immunization. Normal group did not receive
any injection. Test groups were treated intraperitoneally with
Plumbagin (3.3 mg/kg), (6.6 mg/kg) and (13.3 mg/kg) respectively.
Control group was treated with vehicle alone. At the end of the
experiment, mice were sacrificed and Spleenic T lymphocytes
isolated from arthritic mice, Plumbagin treated mice and normal
mice were incubated with 1μg and 2μg of Con A and maintained
the conditions similar to the previous culture experiments. Cultures
supernatants were collected and IFN-g production was estimated by
ELISA. p-value≤0.05 was significant.
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Townes, 1985 [16]. In addition, plumbagin treatment in
arthritic mice stimulated the Con A induced T cell prolif-
eration to the normal levels by stimulating IL-2 levels. T
cells are believed to play a key role in the inflammatory
response of the disease through the production of cyto-
kines with different properties. Prophylactic treatment of
adjuvant induced arthritic rats with a novel anti-inflam-
matory retinoids like 2,4,6,8 -nona tetraenoic acid, reti-
noid Ro236457, increased Con A induced IL-2
production by spleen cells [17]. HWA 486 is a very effec-
tive inhibitor of adjuvant arthritis which restored the
depressed cellular immune reactivity [18]. The treatment
with adjuvant induced arthritic rats with ethanolic root
extract of Plumbago zeylanica on spleenic T cell prolif-
eration compared with rats treated with known standard
anti- inflammatory drugs [19]. Ethylacetate fraction of
root extract of Plumbago zeylanica suppressed collagen
induced arthritis in DBA/1 mice in dose dependent man-
ner [15]. N,N-Dimethylglycine (DMG) and extracts from
the New Zealand green-lipped mussel Perna canaliculus
(Perna) were potent immunomodulators to modify
ongoing immune and/or inflammatory responses.
Extracts of Perna canaliculus derived from Tween-20,
acid, or ethanol treatment were shown to significantly
decrease the production of TNF-a,I L - 1 ,I L - 2 ,a n dI L - 6
as well as hybridoma antibody production [20]. Recently
reports suggested that anti-inflammatory and analgesic
effect of Plumbagin through inhibition of nuclear factor-
kappa B activation [21]. Plumbagin (3.33 mg/kg body
weight) significantly suppresses the total IgG and IgG2a
responses. More recently, an IL-15-Fcg2a fusion protein
was generated that prevented the development of CIA
and also blocked disease progression in an established
disease model. The fusion protein was a construct of a
point mutated IL-15 fused to the constant region of a
murine IgG2a which binds to the IL-15R without indu-
cing signalling, thereby blocking IL-15 [22]. From this
study we can understand that the reduced IgG2a
response by Plumbagin might influence the anti-inflam-
matory cytokine secretion by stimulating Th1 cells.
Conclusion
The above study thus establishes the IgG2a suppression
in Plumbagin treated CIA mice modulated the T cell pro-
liferation through cytokine secretion. It may also have
novel therapeutic role in the pathogenesis of rheumatoid
arthritis. Modulation of cytokine levels in arthritic mice
has also proved to be fruitful in the therapy of disease.
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